Pharmaceutical Technology: News, Analysis & Industry Insights

Features

Podcast: Longevity, China, and AI the talk of the town at BIO Europe 2026

The attending members of Pharmaceutical Technology’s editorial team talk through the key themes and takeaways from the 2026 BIO-Europe conference.

Annabel Kartal Allen

News

Life-extending peptides are likely not around the corner

Frankie Fattorini

News

AstraZeneca acquires bacterial vaccine biotech, Omniose

Annabel Kartal Allen

News

Longevity sector ambitions outpace regulatory and investment frameworks

News

Moderna’s CEO eyes Keytruda-eclipsing future for personalised cancer vaccine

News

VC funding in Europe falls short at early-stage investment hurdles

PremiumFeatures

Democrat midterm landslide spells greater Trump oversight, marginal reforms

News

Lilly-backed Oyster Therapeutics raises $60m for neurological degraders

Analysis

PremiumAnalyst Comment

Lonza is doubling down on US and ADC expansion with its Merck CDMO deal

Dominic Tyer

Features

Podcast: An investor’s guide to preparing your clinical data package

Annabel Kartal Allen

PremiumAnalyst Comment

MSD’s non-oncology sales set to double as Keytruda faces patent cliff

GlobalData Healthcare

PremiumAnalyst Comment

IDWeek 2026: early ensitrelvir PEP may benefit breakthrough and established Covid-19

GlobalData Healthcare

Themes

News

Anthropic plots IPO amid ongoing foray into drug development

Anthropic hopes Powerful AI will “match or exceed the cognitive capabilities of top human experts across scientific disciplines”.

More themes

Partner Content

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

News

Australia starts investigation into OpenAI Medicare breach

Partner Content

How DFE Pharma supports confident continuous manufacturing decisions

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Peripheral Arterial Disease (PAD): Market View, Current and Future Competitive Landscape

$3495.00

Systemic Sclerosis in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Life-extending peptides are likely not around the corner

AstraZeneca acquires bacterial vaccine biotech, Omniose

Longevity sector ambitions outpace regulatory and investment frameworks

Moderna’s CEO eyes Keytruda-eclipsing future for personalised cancer vaccine

VC funding in Europe falls short at early-stage investment hurdles

Democrat midterm landslide spells greater Trump oversight, marginal reforms

Lilly-backed Oyster Therapeutics raises $60m for neurological degraders

Lonza is doubling down on US and ADC expansion with its Merck CDMO deal

Podcast: An investor’s guide to preparing your clinical data package

MSD’s non-oncology sales set to double as Keytruda faces patent cliff

IDWeek 2026: early ensitrelvir PEP may benefit breakthrough and established Covid-19

Anthropic plots IPO amid ongoing foray into drug development

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Peripheral Arterial Disease (PAD): Market View, Current and Future Competitive Landscape

Systemic Sclerosis in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

IDWeek 2026: Conference Highlights

CRO Activity and Intel Report Q3 2026

Acne Vulgaris: Market View, Current and Future Competitive Landscape

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Peripheral Arterial Disease (PAD): Market View, Current and Future Competitive Landscape

Systemic Sclerosis in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

IDWeek 2026: Conference Highlights

CRO Activity and Intel Report Q3 2026

Acne Vulgaris: Market View, Current and Future Competitive Landscape

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing